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study question: Does embryo culture medium inﬂuence pregnancy and perinatal outcome in IVF?
summaryanswer: Embryo culture media used in IVF affect treatment efﬁcacy and the birthweight of newborns.
what is knownalready: Awide variety of culturemedia for human preimplantation embryos in IVF/ICSI treatments currently exists.
It is unknownwhichmedium is best in terms of clinical outcomes. Furthermore, it has been suggested that the culturemedium used for the in vitro
culture of embryos affects birthweight, but this has never been demonstrated by large randomized trials.
study design, size, duration:We conducted a multicenter, double-blind RCT comparing the use of HTF and G5 embryo culture
media in IVF. Between July 2010 andMay2012, 836 couples (419 in theHTF group and417 in theG5 group)were included. The allocatedmedium
(1:1 allocation) was used in all treatment cycles a couple received within 1 year after randomization, including possible transfers with frozen–
thawed embryos. The primary outcome was live birth rate.
participants/materials, setting, methods: Couples that were scheduled for an IVF or an ICSI treatment at one of the six
participating centers in the Netherlands or their afﬁliated clinics.
main results and the role of chance: The live birth rate was higher, albeit nonsigniﬁcantly, in couples assigned to G5 than in
couples assigned to HTF (44.1% (184/417) versus 37.9% (159/419); RR: 1.2; 95% conﬁdence interval (CI): 0.99–1.37; P ¼ 0.08). Number of
utilizable embryospercycle (2.8+ 2.3 versus2.3+ 1.8;P, 0.001), implantation rate after freshembryo transfer (20.2 versus15.3%;P, 0.001)
and clinical pregnancy rate (47.7 versus 40.1%; RR: 1.2; 95% CI: 1.02–1.39; P ¼ 0.03) were signiﬁcantly higher for couples assigned to G5 com-
paredwith those assigned toHTF.Of the 383 liveborn children in this trial, birthweight data from380children (300 singletons (G5: 163,HTF: 137)
and 80 twin children (G5: 38, HTF: 42)) were retrieved. Birthweight was signiﬁcantly lower in theG5 group comparedwith theHTF group,with a
mean difference of 158 g (95% CI: 42–275 g; P ¼ 0.008). More singletons were born preterm in the G5 group (8.6% (14/163) versus 2.2% (3/
137), but singleton birthweight adjusted for gestational age and gender (z-score) was also lower in the G5 than in the HTF group (20.13+ 0.08
versus 0.17+0.08; P ¼ 0.008).
limitations, reasons for caution: This study was powered to detect a 10% difference in live births while a smaller difference
could still be clinically relevant. The effect of other culture media on perinatal outcome remains to be determined.
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wider implications of the findings: Embryo culture media used in IVF affect not only treatment efﬁcacy but also perinatal
outcome. This suggests that the millions of human embryos that are cultured in vitro each year are sensitive to their environment. These ﬁndings
should lead to increased awareness, mechanistic studies and legislative adaptations to protect IVF offspring during the ﬁrst few days of their ex-
istence.
study funding/competing interest(s): This project was partly funded by The NutsOhra foundation (Grant 1203-061) and
March of Dimes (Grant 6-FY13-153). The authors declare no conﬂict of interest.
trial registration number: NTR1979 (Netherlands Trial Registry).
trial registration date: 1 September 2009.
date of first patient’s enrolment: 18 July 2010.
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Introduction
Subfertility is of major clinical and social concern. The most frequently
used treatments of subfertility are IVF and ICSI. The American and Euro-
pean registries of assisted reproductive technology (ART) reported a
total of 697 556 initiated ART cycles in the year 2010 (Centers for
Disease Control and Prevention, 2012; Kupka et al., 2014). In the USA
and Europe, a delivery rate per started cycle was reported of 29 and
24%, respectively (Centers for Disease Control and Prevention, 2012;
Kupka et al., 2014).
Themedium that is used for embryo culture in IVF/ICSI treatments is
considered to play an important role in IVF/ICSI success rates and treat-
ment outcomes. The choice of embryo culture medium has been found
toaffectembryoquality andpregnancy chances (Quinn et al., 1985;Utsu-
nomiya et al., 2002; Balaban and Urman, 2005; Hoogendijk et al., 2007;
Cossiello et al., 2012; Mantikou et al., 2013). However, a recent system-
atic review showed that randomized studies that compare clinical out-
comes of different culture media are limited in number and of low
methodological quality (Mantikou et al., 2013; Youssef et al., 2015).
Thus, it is yet unknown which culture medium leads to the highest live
birth rates after IVF/ICSI, the outcome generally considered to be
most relevant for evaluating IVF programs (Mantikou et al., 2013).
Children born after ARTare at increased risk of adverse perinatal out-
comes, such as preterm birth and low birthweight, when comparedwith
naturally conceived children (Pandey et al., 2012; Fauser et al., 2014;
Henningsen and Pinborg, 2014). This may be due to both intrinsic
patient factors and speciﬁc aspects of the IVF technique (Pinborg et al.,
2013).
Initial reports from a semi-randomized data analysis suggested that
culture media in IVF could affect birthweight of the children (Dumoulin
et al., 2010; Nelissen et al., 2012). The difference in growth was
already detectable during the second trimester of pregnancy (Nelissen
et al., 2013) and was present at least up to the age of 2 years (Kleijkers
et al., 2014). These ﬁndings have, since then, been both supported and
disputed in studies comparing other culture media (Zandstra et al.,
2015).
We conducted a large multicenter, randomized, double-blind trial
comparing live birth rates as well as pregnancy and perinatal outcomes
after IVF using one of the two culture media that have been used world-




In this multicenter RCT, couples were randomly assigned to have their
oocytes and embryos cultured in one of the two media, i.e. G5 (Vitrolife,
Go¨teborg, Sweden) and HTF (Lonza Verviers, Belgium). The end-of-study
participation for a couple was the achievement of a live birth, the passing of
1 year after randomization or withdrawal of consent by the couple. The
study was conducted at six hospital-based IVF centers in the Netherlands
(Academic Medical Center in Amsterdam (AMC), Catharina Hospital in
Eindhoven, St. Elisabeth Hospital in Tilburg, Maastricht University Medical
Center inMaastricht (MUMC),UniversityMedical CenterGroningen inGro-
ningen (UMCG), and Radboud university medical center in Nijmegen
(UMCN)) and four of their afﬁliated clinics (Onze Lieve Vrouwe Gasthuis
in Amsterdam, Gemini Hospital in Den Helder, Scheper Hospital in
Emmen, and Maxima Medical Center in Veldhoven). The study protocol
was approved by theCentral Committee on Research Involving Human Sub-
jects (CCMO) in theNetherlands and by the institutional reviewboards of all




a 1:1 allocation using random block sizes of two and four couples, 1 day
before oocyte retrieval of the ﬁrst cycle. For each individual center, stratiﬁca-
tion was performed for fertilization technique (IVF or ICSI) andmaternal age
(,38 and ≥38 years of age). Allocation sequence and allocated treatment
were fully blinded to participating couples, attending gynecologists, fertility
doctors and outcome assessors. Blinding of the embryologists was not pos-
sible since theyperformed theprocedures in the laboratory.At the endof the
study, when data collection was completed, the allocation sequence was
revealed to the primary investigators.
Participants
Couples that were scheduled for an IVF or ICSI treatment for their ﬁrst
IVF/ICSI cycle ever or ﬁrst IVF/ICSI cycle after a previous successful preg-
nancywereeligible toparticipate in the study.Couples undergoing amodiﬁed
natural cycle, couples for whom IVF was used to prevent the transmission of
human immunodeﬁciency virus, couples undergoing PGD and couples using
ART for fertility preservation were excluded. All participating couples pro-
vided written informed consent for participating in the study and the use of
their data.
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Interventions and IVF procedures
Participating couples were randomly assigned to either the G5 culture
medium group or the HTF culture medium group. The allocated medium
was used in all treatment cycles, including transfers with cryopreserved
embryos that the women received in the year following randomization. All
other treatment procedures, such as ovarian hyperstimulation, follicular as-
piration and oocyte fertilization, were performed according to the routine
IVF/ICSI procedures in each particular center and were identical for both
study groups.
The G5 PLUS culture medium system included G-IVF PLUS medium for
fertilization, G1 PLUS medium for culturing embryos from Day 1 to Day 3
andG2 PLUSmedium for culturing embryos fromDay 3 toDay 4, where ap-
plicable. The G5 PLUS media were ready-to-use media already supplemen-
tedwith human serumalbumin.HTFmediumwasused for cultureof oocytes
and embryos from fertilization up to Day 4 of culture, where applicable. To
keep procedures as similar as possible, HTF embryos were transferred to a
new culture dish containing fresh HTF on Day 3 of culture. HTF was sup-
plemented with 10% Albuman (Sanquin Plasma Products BV, Amsterdam,
the Netherlands).
In case of IVF, oocytes were incubated in dishes containing 50 ml droplets
of G-IVF PLUS or HTF, according to the culture medium allocated to the
couple, with 10 000–100 000 progressivelymotile spermatozoa for fertiliza-
tion. The next morning, cumulus cells were removed and all oocytes were
transferred to a clean dish containing the allocated medium, G1 PLUS or
HTF. On Day 3 of culture, the embryos were transferred to a new dish con-
taining G2 PLUS or HTF.
In case of ICSI, the oocytes were denudated using cumulase (Origio,
Malov, Denmark), hyadase (Origio, Malov, Denmark) or hyase (Vitrolife,
Go¨teborg, Sweden), injected with a single immobilized spermatozoon and
directly thereafter cultured in dishes containing G1 PLUS or HTF according
to the treatment allocation. On Day 3 of culture, the embryos were trans-
ferred to a new dish containing G2 PLUS or HTF.
Embryo culture was performed following the manufacturer′s instructions,
i.e. at378Cand6%CO2 forG5and378Cand5%CO2 forHTF.Three centers
cultured oocytes and embryos in 5% O2 (AMC, MUMC and St. Elisabeth
Hospital), whereas the other three cultured oocytes and embryos in air
(18–20%O2;CatharinaHospital,UMCGandUMCN). Embryomorphology
was assessed daily and the number of cells and the percentage of fragmenta-
tion were scored based on a structured scoring sheet available in all centers
(Alpha Scientists in Reproductive Medicine and ESHRE Special Interest
Group of Embryology, 2011). All embryologists in all centers participate in
a national external online embryo scoring quality control scheme to limit
inter-individual variation in embryo scoring (www.embryo-online.eu).
Embryos of sufﬁcient quality were transferred to the uterine cavity of the
women on Day 2 (UMCG, MUMC) or 3 (AMC, Catharina Hospital,
MUMC, St. Elisabeth Hospital, UMCN) after fertilization according to the
local policies of each participating center. Cryopreservation of supernumer-
ary good quality embryos was performed with a slow freeze technique
according to the local protocol on Day 3 (MUMC, UMCG, UMCN), 4
(AMC,CatharinaHospital, St. ElisabethHospital) or5 (St. ElisabethHospital)
after fertilization. After thawing, the allocated medium was used for culture
and transfer of these embryos. A new IVF/ICSI cycle was initiated only
after all cryopreserved embryos from the previous cycle were thawed and
transferred.
Outcomes
The primary outcome was live birth rate, which was deﬁned as the propor-
tion of couples that achieved a birth of at least one baby born alive, independ-
ent of gestational age (GA). Secondary outcomes were number of utilizable
embryos, implantation rate, biochemical pregnancy, clinical pregnancy,
ongoing pregnancy, miscarriage, birthweight and congenital abnormalities.
The number of utilizable embryos was deﬁned as the number of embryos
transferred plus the number of embryos cryopreserved. The number of
implantations was determined by the number of fetal sacs as identiﬁed by
transvaginal ultrasound examination at 6–8 weeks of gestation. A biochem-
ical pregnancywas deﬁned as a serumbhCG level of at least 50 IU/l 2 weeks
after embryo transfer. Clinical pregnancywas determined by the presence of
a gestational sac and fetal heartbeat conﬁrmed by transvaginal ultrasound
examination at 6–8 weeks of gestation. Ongoing pregnancy was deﬁned as
a viable intrauterine pregnancy after 12 weeks of gestation. A miscarriage
was determined by a biochemical pregnancy not resulting in a live birth.
After delivery, questionnaires were sent to all women and their obstet-
rician or midwife. Questionnaires included questions about ultrasound
examinations, pregnancy characteristics and complications (i.e. gestational
diabetes, hypertension and pre-eclampsia) and perinatal outcome. Con-
genital malformations were classiﬁed as major when they caused functional
impairment or required surgical correction. The remaining congenital mal-
formations were consideredminor (Bonduelle et al., 2002). Actual GAwas
calculatedbasedon thedayof oocyte retrieval,whichwasdeﬁned asDay14
of the cycle. Birthweight percentiles were based on the median weight of a
reference population of children born at the same GA and of the same
gender (Oken et al., 2003). These were used to deﬁne very small for GA
(,3rd percentile), small for GA (,10th percentile), large for GA
(.90th percentile) and very large for GA (.97th percentile) infants and
to calculate z-scores. In case of a twin pregnancy, the inter-twin birthweight
disparity was calculated in grams and the inter-twin birthweight discord-
ance as a percentage by dividing the difference in birthweight by the
weight of the heavier twin and multiplying the result by 100% (Blickstein
and Kalish, 2003).
To investigate fetal growth, data from the ultrasound pregnancy examina-
tions were used. In the Netherlands, all pregnant women are offered ultra-
sound dating during the ﬁrst trimester and are counseled for fetal
ultrasound examination around 20weeks of gestation to have fetal biometry
performed and be screened for structural abnormalities. Furthermore,
women can freely choose to participate in ﬁrst-trimester screening for
Down syndrome. To compare fetal growth between the study groups,
while adjusting for the differences inGA atwhich the examinationswere per-
formed, differences between the estimated GA (based on data from the
ultrasound examinations) and actual GA (oocyte retrieval based) were
used (DGA) and expressed in days. The crown-rump-length (CRL)-based
formula by Hadlock et al. (1992) was used to calculate the GA at 8 and 12
weeks of gestation and the biparietal diameter (BPD)-based formulae by
Mul et al. (1996) #1 and#2 and Selbing and Kjessler (1985)were used to cal-
culate the GA at 20 weeks of gestation (Saltvedt et al., 2004). Furthermore,
fetal weight was estimated based on several sonographic parameters (head
circumference, abdominal circumference, femur length and BPD) that
weremeasured during themid-trimester ultrasound scan at 20weeks of ges-
tation using the Hadlock et al. (1985) I, III and IV formulae (Hoopmann et al.,
2010).
Sample size and interim analysis
Based on a live birth rate of 45% after 1 year of IVF/ICSI treatment in the
participating centers in the years preceding this study, we calculated that
at least 784 women would be needed to detect a difference of 10% in live
birth rate after 1 year of treatment with a power of 80% at an a of 0.05.
More patients were counseled and invited to participate in the study to
allow for dropouts.
One interim analysis of efﬁcacy was planned to be performed 1 year after
the initiation of the study by an independent data and safetymonitoring com-
mittee. Primary outcome of this interim analysis was ongoing pregnancy for
ﬁrst, second and third cycles, including transfers with frozen–thawed
embryos, that had been performed at that time. The data and safety
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monitoring committee had to use these proxy outcomes as otherwise an
interim analysis would not have been possible before the completion of
the inclusion of the study. Live birth data were available only at the end of
the study, due to the design and inclusion rate of the study. For the same
reason, no formal stopping rules or adjusted statistics were applied. A
blinded overview, which was available only to the data and safety monitoring
committee, was used for the interim analysis.
Statistical analysis
We calculated rates of pregnancy and live birth in each group and the corre-
sponding rate ratios (RRs) with 95% conﬁdence intervals (95% CI). Differ-
ences in outcomes were statistically evaluated using x2 statistics for
categorical variables and one-way analysis of variance for continuous vari-
ables.Datawere analyzed according to the intention-to-treatprinciple. Birth-
weight differences between children from the G5 group versus the HTF
group were analyzed by means of general estimating equations (Zeger and
Liang, 1986), in view of the statistical dependence between birthweights
within twin pairs. In addition, being part of a twin was added to the analysis
as a covariable because of its strong association with birthweight. Perinatal
outcome was further investigated in singletons and twins separately, as be-
forehand twinning was considered to be an important confounder and a
treatment-related bias as the study was not designed to include single
embryo transfers only. To investigate the effect of medium on birthweight
controlled for other potential confounders, a multivariable regression ana-
lysis was performed and regression imputation was used for missing data
on parental height, weight and smoking.
Results
Between July 2010 and May 2012, a total of 836 couples were randomly
allocated to undergo IVF/ICSI using either G5 (n ¼ 417) or HTF (n ¼
419) medium for embryo culture (Fig. 1). Four hundred and twelve
couples in the G5 group and 395 couples in the HTF group underwent
the allocated intervention in all their cycles. Five couples in the G5 and
24 couples in the HTF group did not receive the allocated treatment
in one of the performed cycles because of human error in identifying
the couple as participating in the study; in these couples, the medium
used for non-trial participants in that speciﬁc center was used. Only
one couple (in the G5 group) withdrew consent prior to ﬁnishing the
year of treatment, after two cycles. The couple had not achieved preg-
nancy and was analyzed as such. Nineteen couples were allocated in
either of the two culture media without fulﬁlling the inclusion criteria,
the primary reason being that they had undergone one ormore previous
unsuccessful IVF/ICSI treatments. Since our analysis is based on intention-
to-treat, those couples were included in the analysis.
The couples remained enrolled in the study for 1 year after allocation
and in case of an ongoing pregnancy they were followed until delivery.
Only one of the couples with an ongoing pregnancy (in the G5 group)
was lost to follow up. We included this pregnancy as not resulting in a
live birth in our analysis. The baseline characteristics of the couples are
presented in Table I. Four couples (3 in the G5 group and 1 in the HTF
group) received oocyte donation and 22 couples (8 in the G5 group
Figure 1 Flow chart of allocation, follow-up and analysis of the included couples in an RCT of the inﬂuence of embryo culturemedium (G5 andHTF) on
pregnancy and perinatal outcome after IVF.
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and 14 in the HTF group) had treatment with sperm from a donor. In
these cases, the age of the donor was used for the calculation of the
mean maternal and paternal age. No important differences were found
between baseline characteristics of the G5 group and the HTF group,
either among all couples or in the subgroup of couples with a live born
child (Table I).
IVF outcomes
After 1 year of treatment, live birth ratewas not signiﬁcantly different for
women in the G5 group when compared with women in the HTF group
(44.1% (184/417) versus 37.9% (159/419); RR: 1.2; 95%CI: 0.99–1.37;
P ¼ 0.08; mean difference 6.2%, 95% CI: 20.5 to 12.9). Similarly, there
wasnodifference in thepercentageofwomenachieving anongoing preg-
nancy between the G5 group and the HTF group (45.3% (189 of 417)
versus 38.7% (162 of 419); RR: 1.2; 95% CI: 0.99–1.37; P ¼ 0.06).
Women in the G5 group had a signiﬁcantly higher rate of clinical preg-
nancy than women in the HTF group (47.7% (199 of 417) versus
40.1% (168 of 419); RR: 1.2; 95% CI: 1.02–1.39; P ¼ 0.03), whereas
the proportion of miscarriages did not differ between the study groups
(Table II).
A total of 1497 cycles (713 (mean of 1.71) for the G5 group and 784
(mean of 1.87) for theHTF group) were performed (1.71+0.04 versus
1.87+0.04; P ¼ 0.003). There was no difference in the percentage of
cycles with ICSI (58.3% (416 of 713) versus 57.3% (449 of 784); RR:
1.0; 95%CI: 0.93–1.11; P ¼ 0.68) or the proportion of oocyte retrievals
resulting in a fresh transfer (93.0% (663 of 713) versus 93.5% (733 of
784); RR: 1.0; 95% CI: 0.97–1.02; P ¼ 0.76) between the G5 group
and the HTF group (Supplementary Table SI). The percentage of trans-
fers using cryopreserved embryos in theG5 groupwas higher than in the
HTF group (38.7% (276 of 713) versus 26.0% (204 of 784); RR: 1.5; 95%
CI: 1.28–1.73; P, 0.001) (Supplementary Table SI).
The embryo characteristics of all treatments are illustrated in Table III.
Fertilization rate was signiﬁcantly lower in the G5 group than in the HTF
group (62.9% (3655 of 5807) versus 69.1% (4341 of 6286); P, 0.001).
Themean number of utilizable embryos per cycle, i.e. the mean number
of embryos thatwere transferredor cryopreservedper cycle, was signiﬁ-
cantly higher in the G5 group than in the HTF group (2.8+2.3 versus
2.3+ 1.8; P, 0.001). Furthermore, the proportion of embryos that
implanted after fresh transfer was signiﬁcantly higher in the G5 group
than in the HTF group (20.2% (195 of 966) versus 15.3% (171 of
1117); P, 0.001). At the end of the study period, signiﬁcantly more
embryos per woman were still cryopreserved in the G5 group when
compared with the HTF group (mean 1.28+ 0.12 versus 0.79+0.09;
P ¼ 0.001).
Perinatal outcome
Of the 343 pregnancies with live births, 301 were single gestation preg-
nancies (G5: 164, HTF: 137), whereas 42 were multiple gestation preg-
nancies (G5: 20,HTF: 22). In twomultiple gestation pregnancieswith live
births (G5: 1, HTF: 1), one of the fetuses was lost between 12 weeks of
gestation (ongoing pregnancy) and birth. From this, a total of 383 live
born children were included in the study, 165 singleton and 38 (18.7%)
twin children in theG5 group and 138 singleton and 42 (23.3%) twin chil-
dren in the HTF group.
......................................................... .........................................................
.............................................................................................................................................................................................
Table I Baseline characteristics of the couples in an RCT of the inﬂuence of embryo culture medium (G5 and HTF) on
pregnancy and perinatal outcome after IVF.
Characteristic All couples Couples with a live born child
G5 (n5 417) HTF (n 5 419) G5 (n 5 184) HTF (n5 159)
Primary indication for IVF/ICSI
Tubal 47 (11.3) 37 (8.8) 20 (10.9) 12 (7.5)
Male subfertility 211 (50.6) 225 (53.7) 104 (56.5) 94 (59.1)
Unexplained 100 (24.0) 84 (20.0) 34 (18.5) 28 (17.6)
Other 59 (14.1) 73 (17.4) 26 (14.1) 25 (15.7)
Maternal characteristics
Age (years) 33.9+4.3 33.8+4.4 32.9+3.9 33.0+4.1
Height (cm)a n/a n/a 169.8+7.6 171.0+7.0
Weight (kg)a n/a n/a 68.6+12.6 71.1+12.7
Smoking ≥10 cigarettes/daya n/a n/a 13 (7.1) 16 (10.1)
Paternal characteristics
Age (years) 37.5+6.2 37.3+6.4 36.7+6.2 37.0+6.4
Height (cm)a n/a n/a 183.1+7.5 182.9+7.6
Weight (kg)a n/a n/a 87.7+13.6 88.1+13.3
Smoking ≥10 cigarettes/daya n/a n/a 26 (14.1) 21 (13.2)
Duration of subfertility (years) 3.1+1.9 3.1+2.3 3.1+1.8 3.3+2.5
Nulliparous 312 (74.8) 317 (75.7) 133 (72.3) 115 (72.3)
Data presented as mean+ SD or numbers (%). n/a denotes not available.
aData onmaternal height, maternalweight,maternal smoking, paternal height, paternal weight and paternal smokingweremissing from26 (7.6%), 28 (8.2%), 28 (8.2), 27 (7.9%), 32 (9.3%)
and 38 (11.1%) couples, respectively.
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Of the 383 live born children, birthweight data from 380 children
(300 singletons (G5: 163, HTF: 137) and 80 twin children (G5: 38,
HTF: 42)) were retrieved. Birthweight was signiﬁcantly lower in the
G5 group compared with the HTF group, with a mean difference of
158 g (95% CI: 42–275 g; P ¼ 0.008). Separate analysis for singletons
and twins is provided in Tables IV andV, respectively. Birthweight of the
singletons was also signiﬁcantly lower in the G5 group compared with
the HTF group (3299+ 46 g versus 3480+ 44 g; P ¼ 0.005),
whereas there was no difference in birthweight for twins from the G5
or HTF group. Furthermore, singleton birthweight adjusted for GA
and gender (z-score) was lower in the G5 group than in the HTF
group (20.13+ 0.08 versus 0.17+ 0.08; P ¼ 0.008). In the G5
group, more singletons were born preterm (8.6% (14/163) versus
2.2% (3/137); RR: 3.92; 95% CI: 1.15–13.37; P ¼ 0.02) and there
were more singletons with low birthweight (,2500 g) (9.8% (16/
163) versus 2.9% (4/137); RR: 3.36; 95% CI: 1.15–9.82; P ¼ 0.02).
The percentage of children with major or minor malformations did
not differ between the groups (Tables IV and V).
To determine how the effect of culturemediumonbirthweight relates
to the effect of other possible birthweight confounders, a multivariate
analysis was performed. Multiple linear regression indicated that the
adjusted mean birthweight of singletons was 116 g lower in the G5
group than in theHTF group (95%CI:2212 to220; P ¼ 0.02) (Supple-
mentary Table SII). Additionally, in the subgroup of 283 singletons that
were born from term pregnancies (≥37 weeks), the adjusted mean
birthweight of singletons in the G5 group was 100 g lower than in the
HTF group (95% CI: 2198 to 22; P ¼ 0.04). It has been shown that
the duration of culture can affect birthweight in humans (Makinen
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Table II Outcomes in women allocated to G5 and HTF.
Outcome G5 (n5 417) HTF (n5 419) Risk ratio (95% CI)a P-Value
Women with ≥1 child born (live birth rate) 184 (44.1) 159 (37.9) 1.2 (0.99–1.37) 0.08
Total no. of live birthsb 203 180
Women with ≥1 ongoing pregnancyc 189 (45.3) 162 (38.7) 1.2 (0.99–1.37) 0.06
Total no. of ongoing pregnancies 190 163
Women with ≥1 clinical pregnancy 199 (47.7) 168 (40.1) 1.2 (1.02–1.39) 0.03
Total number of clinical pregnancies 205 170
Women with ≥1 biochemical pregnancy 236 (56.6) 210 (50.1) 1.1 (0.99–1.28) 0.06
Total number of biochemical pregnancies 255 221
Women with ≥1 miscarriage 66 (15.8) 56 (13.4) 1.2 (0.85–1.65) 0.33
Total number of miscarriages 71 62
CI, conﬁdence interval.
Data presented as number (%).
aRisk ratio for G5 group when compared with HTF group.
b165 singleton and 38 twin children in the G5 group; 138 singleton and 42 twin children in the HTF group.
cTwo pregnancies with stillborn, two pregnancies with intrauterine deaths and one pregnancy loss to follow-up in the G5 group; one pregnancy with stillborn (twin) and two pregnancies
with intrauterine deaths in the HTF group.
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Table III Embryologic characteristics according to the treatment.
Characteristic G5 HTF P-Value
Cumulus–oocyte complexes: number (mean number per cycle+ SD) 6461 (9.1+5.3) 7102 (9.1+5.4) 0.99
Oocytes inseminated/injected: number (mean number per cycle+ SD) 5807 (8.1+5.0) 6286 (8.0+5.0) 0.62
Fertilized oocytes (embryos)a: number (mean number per cycle+ SD) 3655 (5.1+3.9) 4341 (5.5+4.0) 0.04
Fertilization rate: % per oocytes inseminated/injected 62.9 69.1 ,0.001
Utilizable embryosb: number (mean number per cycle+ SD) 1966 (2.8+2.3) 1779 (2.3+1.8) ,0.001
Embryos transferred in a fresh cycle: number (mean number per transfer+ SD) 966 (1.5+0.6) 1117 (1.5+0.6) 0.19
Implanted embryos from a fresh cycle: number (% of embryos transferred) 195 (20.2) 171 (15.3) ,0.001
Embryos cryopreserved: number (mean number per cycle+ SD) 1000 (1.4+2.4) 662 (0.8+1.8) ,0.001
Cryopreserved embryos transferred: number (mean number per transfer with cryopreserved
embryos+ SD)
325 (1.2+0.6) 225 (1.1+0.6) 0.20
Implanted cryopreserved embryos: number (% of cryopreserved embryos transferred) 35 (10.7) 25 (11.1) 0.89
The differences in outcomes between study groups were tested by one-way analysis of variance.
a2PN zygotes and 1PN/0PN zygotes that cleaved in 48 h.
bNumber of embryos transferred in a fresh cycle or cryopreserved.
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et al., 2013; Zhu et al., 2014b; Kaartinen et al., 2015). Furthermore, it has
been suggested that oxygen concentration during culture can inﬂuence
the effect of culture medium, at least on blastocyst formation in the
mouse (Morbeck et al., 2014a). As those factors are related to center
of treatment in this study, an additional analysis including center of
treatment was performed. It was found that embryo culture medium
(G5 versus HTF) was still associated with singleton birthweight (b ¼
2117 g; 95% CI: 2213 to 220; P ¼ 0.02).
Fetal growth
To investigate the onset of the intrauterine growth difference between
the children from the G5 group and the HTF group, the fetal growth
.............................................................................................................................................................................................
Table V Neonatal outcome of live born twins.
Outcome G5 (n5 38) HTF (n5 42) Risk ratio (95% CI)a P-Value
Female 23 (60.5) 17 (40.5) 1.50 (0.96–2.34) 0.12
GA at birth (weeks) 35.6+0.4 35.1+0.4 0.47
Preterm birth (,37 weeks) 26 (68.4) 30 (71.4) 0.96 (0.72–1.28) 0.81
Very preterm birth (,32 weeks) 4 (10.5) 8 (19.0) 0.55 (0.18–1.69) 0.36
Low birthweight (,2500 g) 21 (55.3) 28 (66.7) 0.83 (0.58–1.19) 0.36
Low birthweight with GA ≥ 37 weeks 4 (10.5) 4 (9.5) 1.11 (0.30–4.12) 1.00
Very low birthweight (,1500 g) 6 (15.8) 5 (11.9) 1.33 (0.44–4.00) 0.75
Major malformations 1 (2.6) 2 (4.8) 0.55 (0.05–5.85) 1.00
Minor malformations 1 (2.6) 0 (0.0) n/a 0.48
Birthweight (g) 2266+100 2267+94 0.99
Birthweight disparity (g) 426+64 289+40 0.07
Birthweight discordance (%) 17.1+2.4 12.4+1.7 0.11
Birthweight discordance (≥25%) 10 (26.3) 8 (19.0) 1.38 (0.61–3.14) 0.59
n/a, not applicable.
Data presented as means+ SEM or numbers (%).
aRisk ratio for G5 group when compared with HTF group.
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Table IV Neonatal outcome of live born singletons.
Outcome G5 (n5 163) HTF (n5 137) Risk ratio (95% CI)a P-Value
Female 71 (43.6) 65 (47.4) 0.92 (0.72–1.18) 0.56
Birthweight (g) 3299+46 3480+44 0.005
z-Score 20.13+0.08 0.17+0.08 0.008
GA at birth (weeks) 39.2+0.1 39.4+0.1 0.19
Preterm birth (,37 weeks) 14 (8.6) 3 (2.2) 3.92 (1.15–13.37) 0.02
Very preterm birth (,32 weeks) 1 (0.6) 0 (0.0) n/a 1.00
Low birthweight (,2500 g) 16 (9.8) 4 (2.9) 3.36 (1.15–9.82) 0.02
Low birthweight with GA ≥ 37 weeks 6 (3.7) 3 (2.2) 1.68 (0.43–6.60) 0.52
Very low birthweight (,1500 g) 1 (0.6) 0 (0.0) n/a 1.00
High birthweight (.4500 g) 1 (0.6) 4 (2.9) 0.21 (0.02–1.86) 0.18
Small for GA (,10th percentile) 14 (8.6) 5 (3.6) 2.35 (0.87–6.37) 0.10
Very small for GA (,3rd percentile) 4 (2.5) 1 (0.7) 3.36 (0.38–29.73) 0.38
Large for GA (.90th percentile) 15 (9.2) 16 (11.7) 0.79 (0.41–1.54) 0.57
Very large for GA (.97th percentile) 2 (1.2) 7 (5.1) 0.24 (0.05–1.14) 0.09
Major malformations 4 (2.5) 6 (4.4) 0.56 (0.16–1.95) 0.52
Minor malformations 6 (3.7) 6 (4.4) 0.84 (0.28–2.55) 0.78
GA, gestational age; n/a, not applicable
Data presented as mean+ SEM or numbers (%). The differences in outcomes between study groups were tested by one-way analysis of variance for continuous variables and x2 test for
categorical variables.
aRisk ratio for G5 group when compared with HTF group.
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patterns in single gestation pregnancies were compared between the
study groups. Around 8 weeks of gestation, fetal CRL was retrieved in
149 (90.9%) single gestation pregnancies from the G5 group and 129
(94.2%) single gestation pregnancies from the HTF group. Not all
women participated in the Down screening around 12 weeks of gesta-
tion, and fetal CRLwas retrieved in only 114 single gestationpregnancies,
60 (36.6%) in the G5 group and 54 (39.4%) in the HTF group. In the
screening for structural abnormalities of the fetus around 20 weeks of
gestation, not all biometric parameters used to calculate theDGAoresti-
mated fetalweight (EFW)weremeasured in allwomen. ForDGAaround
20 weeks of gestation, data from 139 (84.8%) pregnancies from the G5
group and 110 (80.3%) pregnancies from the HTF group were analyzed,
whereas for EFW, data from 138 (84.1%) G5 pregnancies and 111
(81.0%) HTF pregnancies were analyzed. Intrauterine growth of single-
tons from single gestation pregnancies is presented in Table VI. The dif-
ferences between the CRL- or BPD-based GA and actual (oocyte
retrieval based) GA were not different between the study groups at 8,
12 and 20weeks of gestation. Furthermore, the EFWat 20weeks of ges-
tation, as calculated with three different formulae by Hadlock, did not
differ between the two study groups.
Discussion
In this randomized double-blinded trial, we evaluated the effect of two
embryo culture media that are used in IVF/ICSI treatments and found
a 6% difference in live births in favor of G5 medium. Despite the
absence of a statistical signiﬁcance in the difference in live birth rate
(G5 versusHTF; RR: 1.2; 95%CI: 0.99–1.37), we conclude thatG5 pro-
vides better treatment success than HTF, as other outcomes that are
relevant for IVF and correlate to live birth rate, all signiﬁcantly favored
G5. This includes clinical pregnancy, number of utilizable embryos,
number of embryos implanted after fresh transfer and the number of
cryopreserved embryos that remained available at the end of the
study. The beneﬁcial effect of G5 on all these outcomes but live birth
rate is probably due to the study being powered to detect a 10% differ-
ence in live births. Future designs should include a larger number of
patients tobe able to establish smaller differences,which are still clinically
relevant.
Birthweightwas signiﬁcantly lower in children fromtheG5group com-
paredwith children from theHTF group, with amean difference of 158 g
(95% CI: 42–275 g; P ¼ 0.008). In previous studies with consecutive or
alternate use of different culturemedia, some reported effects of culture
medium on birthweight (Dumoulin et al., 2010; Nelissen et al., 2012;
Eskild et al., 2013; Hassani et al., 2013; Zhu et al., 2014a,b), whereas
others foundnoeffect (Eaton et al., 2012;Vergouw et al., 2012;Carrasco
et al., 2013; Lin et al., 2013; Ziebe et al., 2013; Lemmen et al., 2014;
Wunder et al., 2014) [see review by Zandstra et al. (2015)]. We now,
for the ﬁrst time by means of a large RCT, conﬁrm that embryo culture
medium can have an effect on birthweight in humans. The clinical rele-
vance of a difference in birthweight after IVF, the mechanism through
which a few days of embryo culture affects birthweight 9 months later,
and a more optimal composition of culture media for IVF must now be
determined.
There were more preterm births, with lower birthweight, among sin-
gletons in the G5 group. This does not fully explain; however, the
observed difference in birthweight as well as the z-score (birthweight
adjusted for GA and gender) was signiﬁcantly lower in the G5 group
than in the HTF group. It is well known that children born after ART
have a higher risk for preterm birth and low birthweight compared
with children born after natural conception (Henningsen and Pinborg,
2014). Our study suggests embryo culture medium composition is one
of the causative factors for this.
The fetal growth patterns from both study groups did not differ up to
20 weeks of gestation, which indicates that the onset of the growth dif-
ferentiation is distinguishable only after this period. This is not in agree-
ment with a study by Nelissen et al. (2013), in which it was found that
the fetal growth patterns diverged already at 20 weeks of gestation
after the use of two different culture media. It has been suggested that
many ART procedures, including certain culture conditions, are asso-
ciatedwith fetal growth restriction in early tomid-pregnancy, succeeded
by substantial increases in placental size and accelerated fetal growth
toward the end of gestation (Bloise et al., 2014). In mice, it was shown
that culture medium composition highly determines fetal weight after
ART (Delle Piane et al., 2010).
Although speculative, the effects that embryo culture media have on
birthweight of newborns could be mediated through a direct effect on
the epigenome of the developing preimplantation embryo (van Mon-
tfoort et al., 2012). In recent publications, we demonstrated that the
use of G5 and HTF resulted in different gene expression proﬁles in
human preimplantation embryos at the blastocyst stage (Kleijkers
et al., 2015; Mantikou et al., 2016). A side-by-side comparison of ﬁve
human culture media indicated that all had a varying but compromised
ability to maintain gene expression and DNA methylation patterns in
mouse preimplantation embryos when compared with in vivo-derived
embryo (Market-Velker et al., 2010). Alternatively, it could be that
embryo culture media affect the ability of preimplantation embryos to
properly implant. In such a scenario, the observed lower birthweight,
as well as the increased incidence of preterm birth, would be an indirect
effect of culture media via disturbed implantation.
It is too early to know whether a difference of 158 g in birthweight
has any clinical signiﬁcance. However, an inverse association between
........................................................................................
Table VI Fetal growth in single gestation pregnancies
with a live birth.
Outcome G5 HTF P-Value
8 weeks of gestation (n) 149 129
DGA; Hadlock et al. (1992) 20.4+0.1 20.5+0.2 0.762
12 weeks of gestation (n) 60 54
DGA; Hadlock et al. (1992) 2.3+0.7 3.6+0.9 0.244
20 weeks of gestation (n) 139 110
DGA; Mul et al. (1996) (#1) 1.2+0.4 0.7+0.4 0.360
DGA; Mul et al. (1996) (#2) 0.8+0.4 0.3+0.4 0.342
DGA; Selbing and Kjessler
(1985)
3.7+0.4 3.1+0.5 0.421
20 weeks of gestation (n) 138 111
EFW; Hadlock I (g) 335+4 343+5 0.199
EFW; Hadlock III (g) 341+4 349+5 0.230
EFW; Hadlock IV (g) 331+4 340+5 0.197
EFW, estimated fetal weight.
Data are presented as mean+ SEM.
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birthweight and increased ratesof coronary heart disease and the related
disorders of stroke, hypertension and Type 2 diabetes during adult life
has previously been demonstrated (Barker, 1997). This has led to the
Barker or developmental origin of health and disease (DOHaD) hypoth-
esis,which suggests that the fetus is sensitive to its (uterine) environment,
and that adaptations of the fetus to its environment have lasting conse-
quences for its development, growth and health. A well-known
example of the DOHaD hypothesis is the ﬁnding that individuals con-
ceived during the Dutch famine of the World War II have higher rates
of coronary heart disease, a more atherogenic lipid proﬁle, disturbed
blood coagulation, increased stress responsiveness and are more often
obese than unexposed individuals or those exposed during mid- or late-
gestation, evenwithout aneffect onbirthweight (Roseboom et al., 2011).
It has alsobeen suggested thatpreimplantationembryosorevengametes
adapt to their altering environment in response to parental diet with
long-term consequences for health of the future adult (Carone et al.,
2010; Fleming et al., 2012; Lucas, 2013).
One of the differences between the embryo culture media is that the
G5medium contains certain amino acids and that theHTFmedium com-
pletely lacks amino acids. Studies in human and animal embryos have
shown that the embryo development in vitro can indeed be improved
by the addition of amino acids to the culture medium (Liu and Foote,
1995; Devreker et al., 1998; Lane and Gardner, 1998; Summers and
Biggers, 2003). The importance of amino acids during preimplantation
embryo development also stems from studies in which mice were
given a low protein diet (LPD) only during the period of conception.
The offspring had a higher birthweight and blood pressure, even when
the embryos were transferred to a pseudo-pregnant mouse that did
not have the LPD during conception (Watkins et al., 2008; Fleming
et al., 2012). We are not aware of any study that has looked speciﬁcally
at the effect of amino acids in embryo culture media on pregnancy rates,
live births or perinatal outcome in humans. Other notable differences in
composition are the addition of hyaluronan and lipoic acid to G5. A
meta-analysis showed that the use of hyaluronan-enriched transfer
media resulted in increased implantation and live birth rates (Bontekoe
et al., 2014). Although lipoic acid is thought to improve mouse embryo
development via its role as antioxidant (Talebi et al., 2012), no studies
have evaluated its effect on pregnancy or live birth rates in humans and
no studies have looked at the effect of hyaluronan- or lipoic acid enrich-
mentof embryo culturemediaonperinatal outcome.Theprotein source
in the culture media is also an important candidate in this respect, as the
quality of it has been shown tovary considerably betweenbatches aswell
as between manufacturers (Dyrlund et al., 2014; Morbeck et al., 2014b)
and the protein source has previously been suggested to inﬂuence live
birth rate (Meintjes et al., 2009) and birthweight (Zhu et al., 2014a).
It is relevant to note that HTF was widely used for many years in IVF
worldwide, but has lost signiﬁcant market share in recent years. Embry-
ologists nowseemtopreferother,more ‘enrichedmedia’, i.e.media that
contain additives such as thepreviouslymentionedaminoacids. Still,HTF
is not completely removed from themarket. At the time of study design,
8 out of the 13 IVF centers in the Netherlands used HTF medium to
culture preimplantation embryos. Based on the Dutch national reports
of the IVF results (NVOG), there were no clear differences in ongoing
pregnancy rates between centers using HTF medium and the other
centers. Two small studies published as abstracts indicated that G2
medium (G2 is an earlier version of G5 and is no longer on the
market) had a higher efﬁcacy than HTF medium (Bisioli et al., 2003;
Choi et al., 2004); however, well-designed RCTs comparing these
media to more classic media were lacking. Proper trials to support
these assumptions are very much needed according to the good clinical
practice guidelines (Mantikou et al., 2013).
Over 20 other embryo culture media are commercially available. A
trial comparing all available culture media simultaneously is simply not
possible. Nevertheless, such an essential component of IVF should be
treated with the highest level of scrutiny, and there is a need for more
well-designed RCTs on media for human embryo culture focusing not
only on pregnancy rates but also on birthweight and child health. In add-
ition, the full composition of embryo culturemedia should bemade pub-
lically available by the companies that produce them (Summers and
Biggers, 2003). Recently, a composition analysis of certain components
was performed for some embryo culture media, but not all (Morbeck
et al., 2014a). The formulations should have a scientiﬁc rationale and
the introduction of new media into clinical practice should be based on
properly conducted RCTs. Companies should also report what studies
have been performed to test these media and which end-points have
been analyzed. In our view, the responsibility for proper introduction
of embryo culture media with new formulations lies not only with the
manufacturers, but also with clinical embryologists that decide to imple-
ment these culture media in clinical practice. The legislative background
behind IVF culture media is such that there are limited constraints on
introducing new culture media, even if they contain new growth
factors of unknown effect on pregnancy rates, let alone the health of chil-
dren born. We feel the time has come to radically shift gears in our ﬁeld
and that we should no longer blindly accept new culturemedia (or other
alterations in laboratory or clinical procedures) without ﬁrst rigorously
studying effectiveness and safety, not unlike the introduction of new
drugs or medical devices.
Ongoing pregnancy or live birth rate is generally considered to be the
most important outcome after IVF (Land and Evers, 2003; Braakhekke
et al., 2014). Our study should raise awareness of the fact that perinatal
outcomes are just as important and that follow-up procedures should be
an integral part of the treatment protocol in every IVF center worldwide.
It hasbeenwell argued thatprofessionals in theﬁeldof reproductionhave
the moral obligation to set up effectiveness and safety studies, and that
the liability in this cannot simply be left to the patient by means of
‘informed consent’ (Dondorp and de Wert, 2011). While a patient
could in principle agree to being treated with a technique of unknown
safety and effectiveness, the clinician still remains responsible for what
he or she does (Dondorp and de Wert, 2011).
In conclusion, we have demonstrated a signiﬁcant effect of embryo
culturemedia used in IVF on pregnancy outcome and on the birthweight
of newborns. This suggests that the millions of human embryos that are
cultured in vitro each year are sensitive to their environment. These ﬁnd-
ings should lead to increased awareness, mechanistic studies and legisla-
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